Skip to main content
logo
Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
18.00
+0.17 (0.95%)
Nov 24, 2025, 4:00 PM EST - Market closed

Avalo Therapeutics Revenue

In the year 2024, Avalo Therapeutics had annual revenue of $441.00K, down -77.08%.

Revenue (ttm)
$441.00K
Revenue Growth
-77.08%
P/S Ratio
1,700.06
Revenue / Employee
$8,348
Employees
23
Market Cap
326.41M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024441.00K-1.48M-77.08%
Dec 31, 20231.92M-16.13M-89.34%
Dec 31, 202218.05M12.65M234.40%
Dec 31, 20215.40M-1.30M-19.42%
Dec 31, 20206.70M-51.35K-0.76%
Dec 31, 20196.75M-278.03K-3.96%
Dec 31, 20187.03M-20.78M-74.73%
Dec 31, 201727.81M26.66M2,312.27%
Dec 31, 20161.15M--
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

AVTX News

More News